Bristol-Myers, Alder To Pursue Rheumatoid Arthritis Drug Tests - Wall Street Journal

Bristol-Myers, Alder To Pursue Rheumatoid Arthritis Drug Tests Wall Street Journal ACR scores are a standardized measure of percentage improvement in rheumatoid arthritis signs and symptoms. The most commonly reported side effects were ... New Data for Investigational Antibody Blocking IL-6 in Rheumatoid Arthritis ...MarketWatch (press release) Bristol-Myers says arthritis drug trial met goalReuters all 90 news articles »

Pfizer Opts for Earlier-Stage CD20 Program from Trubion - BioWorld Online

Pfizer Opts for Earlier-Stage CD20 Program from Trubion BioWorld Online ... than a month after Phase III-stage anti-CD20 antibody ocrelizumab dropped out of the race to market in the already crowded rheumatoid arthritis space, ... and more »

An agonising delay: For seven months doctors failed to spot Elizabeth's ... - Daily Mail

An agonising delay: For seven months doctors failed to spot Elizabeth's ... Daily Mail 'She pointed out that my father's rheumatoid arthritis had also started with sudden pains in the shoulder and arm, and urged me to go back to my GP and ask ... and more »

Two-year Cimzia® (certolizumab pegol) data from study showed sustained ... - PR-inside.com (press release)

Two-year Cimzia® (certolizumab pegol) data from study showed sustained ... PR-inside.com (press release) The recommended starting dose of Cimzia® for adult patients with rheumatoid arthritis is 400 mg (as 2 injections of 200 mg each on one day) at weeks 0, ...